Drug-induced linear IgA bullous dermatosis;Dermatoses bulleuses à IgA linéaire d'origine médicamenteuse

Nephrologie

Volumn 24, Issue 6, 2003, Pages 287-292

  Montagnac, R ^a   Reguiai Z ^b   Mehaut S ^b   Bressieux, J M ^b   Schillinger, F ^b  

^a CENTRE HOSPITALIER DE TROYES   (France)

^b NONE

Author keywords

Autoimmune disease; Drug eruption; Linear IgA bullous dermatosis; Skin disease; Vancomycin

Indexed keywords

AMIODARONE; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; FUROSEMIDE; GLIBENCLAMIDE; IMMUNOGLOBULIN A; INTERFERON; INTERLEUKIN 2; LITHIUM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PHENYTOIN; RIFAMPICIN; VANCOMYCIN; VIGABATRIN;

ARTICLE; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; INFECTION; LINEAR IGA BULLOUS DERMATOSIS; LYMPHOPROLIFERATIVE DISEASE; RISK FACTOR;

ANTI-BACTERIAL AGENTS; DRUG ERUPTIONS; HUMANS; IMMUNOGLOBULIN A; SKIN DISEASES, VESICULOBULLOUS; VANCOMYCIN;

EID: 0141533031     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Chorzelski TP, Jablonska S, Beutner EH, Bean SF, Furey NL. Linear IgA bullous dermatosis: in: Beutner EH, Chorzelski TP, Bean SF (eds): Immunopathology of the skin. New York: John Wiley and Sons, 1979; 315-23.
2. Leonard JN, Haffenden GP, Ring NP, Mc Minn RMH, Sidgwick A, Mowbrays JF, Unsworth DJ, Holborow EK, Blenkinsopp WK, Fry L. Linear IgA disease in adults. Br J Dermatol 1982; 107: 301-15.
3. Wilson BD, Beutner EH, Kumar V, Chorzelski TP, Jablonska S. Linear IgA bullous dermatosis: An immunologically defined disease. Int J Dermatol 1985; 24: 569-74.
4. Combemale P, Prost C. Maladie à IgA linéaire de I'adulte. Ann Dermatol Venereol 1987; 114: 1605-15.
5. Bhogal BS, Wojnarowska F, Marsden RA, Das A, Black MM, Mc Kee Ph. Linear IgA disease in adults and children: A microscopic study. Br J Dermatol 1987; 17: 289-96.
6. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 1988; 119: 161-70.
7. Wojnarowska F, Marsden RA, Bhogal BS, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immuno-pathologic overlap. J Am Acad Dermatol 1988; 19: 792-805.
8. Wojnarowska F, Whitehead P, Leigh IM, Bhogal BS, Black MM. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991; 124: 157-62.
9. Wojnarowska F, Allen J, Collier P. Linear IgA disease: A heterogeneous disease. Dermatology 1994; 189 (Suppl. 1): 52-6.
10. Wojnarowska F, Bhogal BS, Black MM. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases. Br J Dermatol 1994; 131:201-4.
11. Palmer RA, Ogg G, Allen J, Banerjee A, Ryatt KS, Ratnavel R, Wojnarowska F. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 2001; 145: 816-20.
12. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990; 85: 812-20.
13. Zone JJ, Taylor TB, Meyer IJ, Petersen MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoide antigen, BPAg2. J Invest Dermatol 1998; 110: 207-10.
14. Ishiko A, Shimizu H, Masunaga T, Yancey KB, Giudice GJ, Zone JJ, Nishikawa T. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen. J Invest Dermatol 1998; 111: 93-6.
15. Wojnarowska F, Zhou S, Alllen J, Ferguson DJR Linear IgA disease heterogeneity of antigens with regard to localisation and molecular weight between and within patients. J Invest Dermatol 1998; 110: 511.
16. Klein PA, Callen JP, Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol 2000; 42: 316-23.
17. Vignon D, Guillaume JC, Revuz J, Touraine R. Association maladie de Hodgkin et dermatose à IgA linéaire. Presse Med 1982; 11: 603-4.
18. Kienzler JL, Blanc D, Laurent R, Agache P. Dermatose bulleuse à IgA linéaire et maladie de Hodgkin. Ann Dermatol venereol (Paris) 1983; 110: 727-8.
19. Mobacken H, Kastrup W, Ljunghall K, Lofbey H, Nilsson LA. Linear IgA dermatosis: A study of ten adult patients. Acta Derm Venereol (Stockholm) 1983; 63: 123-8.
20. Sekula SA, Tschen JA, Bean SF, Wolf JE. Linear IgA bullous disease in a patient with transitionnal cell carcinoma of the bladder. Cutis 1986; 38: 354-62.
21. Green ST, Natarajan S. Linear IgA disease and oesophageal carcinoma. J Royal Soc Med 1987; 80: 48.
22. Barnadas MA, Moreno A, Brunet S, Gonzalez MJ, Rodriguez JL, Gelpi C, de Moragas JM. Linear IgA bullous dermatosis associated with Hodgkin's disease. J Am Acad Dermatol 1988; 19: 1122-4.
23. Espagne E, Prost C, Chosidow O, Saiag Ph, Revuz J, Roujeau JC. Dermatoses à IgA linéaire médicamenteuses. A propos de 3 cas. Ann Dermatol Venereol 1990; 117: 898-99.
24. Godfrey K, Wojnarowska F, Leonard J. Linear IgA disease of adults: Association with lymphoproliferative malignancy and possible role of triggering factors. Br J Dermatol 1990; 123: 447-52.
25. Guillaume JC, Escudier B, Espagne E, Roujeau JC, Prost C, Domart P, Nitenberg G, Avril MF. Dermatose bulleuse avec dépôts linéaires d'IgA le long de la membrane basale au cours d'un traitement par l'interféron gamma et l'interleukine 2. Ann Dermatol Venereol 1990; 117: 899-902.
26. Carpenter S, Berg D, Sidhu-Malik N, Hall RP 3rd, Rico MJ. Vancomycin-associated linear IgA dermatosis. A report of three cases. J Am Acad Dermatol 1992; 26: 45-8.
27. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 187-92.
28. Richards SS, Hall S, Yokel B, Whitmore E. A bullous eruption in an elderly woman. Vancomycin-associated linear IgA dermatosis (LAD). Arch Dermatol 1995; 131: 1447-52.
29. Tranvan A, Pezen DS, Medenica M, Michelson GC, Vogelzang N, Soltani KM. Interleukin-2 associated linear IgA bullous dermatosis. J Am Acad Dermatol 1996; 35: 865-7.
30. Whitworth JM, Thomas I, Peltz SA, Sullivan BC, Wolf AH, Cytryn AS. Vancomycin-induced linear IgA bullous dermatosis (LABD). J Am Acad Dermatol 1996; 34: 890-1.
31. Del Pozo J, Martinez W, Yebra-Pimentel MT, Almagro M, Pena-Penabad C, Fonseca E. Linear immunoglobulin A bullous dermatosis induced by gemcitabine. Ann Pharmacother 2001; 35: 891-3.
32. Thune P, Eeg-Larsen T, Nilsen R. Acute linear IgA dermatosis in a child following varicella. Arch Dermatol 1984; 120: 1237-8.
33. Blickenstaff RD, Perry HO, Peters MS. Linear IgA deposition associated with cutaneous varicella-zoster infection: A case report. J Cutan Pathol 1988; 15: 49-52.
34. Janniger CK, Wiltz H, Schwartz RH, Kowalewski C, Lambert WC. Adult linear IgA bullous dermatosis: A polymorphic disorder. Cutis 1990; 45: 37-42.
35. Piketty C, Meeus F, Nochy D, Poux JM, Jacquot C, Bariety J. Linear IgA dermatosis related to vancomycin. Br J Dermatol 1994; 130: 130-1.
36. Geissmann C, Beylot-Barrv M, Doutre MS, Beylot C. Drug-induced linear IgA bullous dermatosis (letter). J Am Acad Dermatol 1995; 32: 296.
37. Bitman LM, Grossman ME, Ross H. Bullous drug eruption treated with amputation. A challenging case of vancomycin-induced linear IgA disease. Arch Dermatol 1996; 132: 1289-90.
38. Bernstein EF, Schuster M. Linear IgA bullous dermatosis associated with vancomycin. Ann Intern Med 1998; 129: 508-9.
39. Danielsen AG, Thomsen K. Vancomycin-induced linear IgA bullous disease. Br J Dermatol 1999; 141: 756-7.
40. Nousari HC, Kimyai-Asadi A, Caeiro JP, Anhalt GJ. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999; 78: 1-8.
41. Yawalkar N, Reimers A, Hari Y, Hunziker T, Gerber H, Müller U. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology 1999; 199: 25-30.
42. Ahkami R, Thomas I. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection. Cutis 2001; 67: 423-6.
43. Wiadrowski TP, Reid CM. Drug-induced linear IgA bullous disease following antibiotics. Australas J Dermatol 2001; 42: 196-9.
44. Primka 3rd EJ, Liranzo MO, Bergfeld WF, Dijkstra JW. Amiodarone-induced linear IgA disease. J Am Acad Dermatol 1994; 31: 809-11.
45. Gabrielsen TO, Staerfelt F, Thune PO. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereol 1981; 61: 439-41.
46. Valsecchi R, Serra M, Tornaghi A, Cainelli T. Dermatosi bollosa da farmaco a IgA lineari. G Ital Dermatol Venereol 1982; 117: 221-3.
47. Paul C, Wolkenstein P, Prost C, Caux F, Rostoker G, Helier M, Wechsler J, Revuz J, Roujeau JC. Drug-induced linear IgA disease: Target antigens are heterogeneous. Br J Dermatol 1997; 136: 406-11.
48. Camilleri M, Pace JL. Linear IgA bullous dermatosis induced by piroxicam. J Eur Acad Dermatol Venereol 1998; 1: 78-9.
49. Petit D, Boradori L, Rybojad M, Morel P. Linear IgA bullous dermatosis after heart transplantation. J Am Acad Dermatol 1990; 22: 851.
50. Cerottini JP, Ricci C, Guggisberg D, Panizzon RG. Drug induced linear IgA bullous dermatosis probably induced by furosemide. J Am Acad Dermatol 1999; 41: 103-5.
51. Vaatainen N, Fraki JE, Hyvonen M, Neittaanmaki H. Purpura with a linear epidermo-dermal deposition of IgA. Acta Derm Venereol 1983; 63: 169-70.
52. Argenyi ZB, Bergfeld WF, Valenzuela MJ, Mc Mahon JT, Taylor JS. Adult linear IgA disease associated with an erythema multiform-like drug reaction. Cleve Clin J Med 1987; 54: 445-50.
53. Klein LE, Shmunes E, Carter JB. Linear IgA bullous dermatosis related to captopril treatment. Cutis 1989; 44: 393-6.
54. Friedman IS, Rudikoff D, Phelps RG, Sepadin AN. Captopril triggered linear IgA bullous dermatosis. Int J Dermatol 1998; 37: 608-11.
55. Hughes AP, Callen JP. Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. Dermatology 2001; 202: 138-9.
56. Lemarchand-Venencie F, Vigouroux F, Blanc F, Pawin H, Pons A, Bonvalet D. Dermatose bulleuse à IgA linéaire au décours immédiat d'une urographie intra-veineuse. Arch Dermatol Venereol 1987; 114: 1423-5.
57. Mc Whirter JD, Hashimoto K, Fayne S, Ito K Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol 1987; 123: 1120-2.
58. Boffety B, Sohier J, Venencie PY. Dermatoses bulleuses à IgA linéaire. Journées dermatologiques de Paris, 1981; 53-53a.
59. Combemale P, Gauvaud C, Cozzani E, Nicolas JF, Guennoc B, Dusseau JY. Dermatose à IgA linéaire induite par la pénicilline G. Ann Dermatol Venereol 1993; 120: 847-8.
60. Wakelin SH, Allen J, Zhou S, Wojnarowska F. Drug induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 1998; 138: 310-4.
61. Acostamadiedo JM, Perniciaro C, Rogers RS 3rd. Phenytoin-induced linear IgA bullous disease. J Am Acad Dermatol 1998; 38: 352-6.
62. Baden JA, Apovian C, Imber MJ, Dover JS. Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 1988; 124: 1186-8.
63. Nousari HC, Costarangos C, Anhalt GJ. Vancomycin-associated linear IgA bullous dermatosis. Ann Intern Med 1998; 129: 507-8.
64. Collier PM, Wojnarowska F. Drug-induced linear Immunoglobulin A disease. Clin Dermatol 1993; 11: 529-33.
65. Camilleri M, Pace JL. Drug-induced linear immunoglobulin-A bullous dermatosis. Clin Dermatol 1998; 16: 389-91.
66. Cantu TG, Dick JD, Elliott DE, Humphrey RL, Kornhauser DM. Protein binding of vancomycin in a patient with immunoglobulin A myeloma. Antimicrob Agents Chemother 1990; 34: 1459-61.